Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRSP compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRSP
CRISPR Therapeutics AG
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CRSP: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CRSP
5
LLY
Eli Lilly
customer
VRTX
Vertex
customer
VERX
Vertex Pharmaceuticals
customer
ACET
Adicet Bio
customer
1 more · CRSP chain
›
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CRSP, solid
AMGN, dashed
CRSP
CRISPR Therapeutics AG
Change
51.38
▼
−5.31%
· post 51.38
Mkt cap
$5.0B
Revenue
$10M
Q2 FY26
Revenue
$4M
FY25
AMGN
Amgen Inc
Change
466.31
▲
+1.21%
· post 466.40
Closed
Oct 30 '26
Mkt cap
$251.9B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Oct 30 '26
CRSP
CRISPR Therapeutics AG
vs
AMGN
Amgen Inc
51.38
▼
−5.31%
post 51.38
Price
466.31
▲
+1.21%
post 466.40
$5.0B
Mkt cap
$251.9B
Q2 FY26
$10M
Revenue
$10.1B
Q2 FY26
FY25
$4M
Revenue
$36.8B
FY25
Change
Change
CRSP
51.38
▼
−5.31%
vs
AMGN
466.31
▲
+1.21%
Closed
Oct 30 '26